Metabolomic Serum Profiling Detects Early-Stage High-Grade Serous Ovarian Cancer in a Mouse Model
- Autores
- Jones, Christina M.; Monge, Maria Eugenia; Kim, Jaeyeon; Matzuk, Martin M.; Fernández, Facundo M.
- Año de publicación
- 2015
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Ovarian cancer is a deadly disease killing more than any other gynecologic cancer. Nonspecific symptoms, combined with a lack of early detection methods, contribute to late diagnosis and low five-year survival rates. High-grade serous carcinoma (HGSC) is the most common and deadliest subtype that results in 90% of ovarian cancer deaths. To investigate metabolic patterns for early detection of this deadly ovarian cancer, Dicer- Pten double knockout (DKO) mice that phenocopy many of the features of metastatic HGSC observed in women were studied. Using ultraperformance liquid chromatography−mass spectrometry (UPLC−MS), serum samples from 14 early-stage tumor (ET) DKO mice and 11 controls were analyzed in depth to screen for metabolic signatures capable of differentiating early-stage HGSC from controls. Iterative multivariate classification selected 18 metabolites that, when considered as a panel, yielded 100% accuracy, sensitivity, and specificity for classification. Altered metabolic pathways reflected in that panel included those of fatty acids, bile acids, glycerophospholipids, peptides, and some dietary phytochemicals. These alterations revealed impacts to cellular energy storage and membrane stability, as well as changes in defenses against oxidative stress, shedding new light on the metabolic alterations associated with early ovarian cancer stages.
Fil: Jones, Christina M.. Georgia Institute of Technology. School of Chemistry & Biochemistry; Estados Unidos
Fil: Monge, Maria Eugenia. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Bionanociencias "Elizabeth Jares Erijman"; Argentina. Georgia Institute of Technology. School of Chemistry & Biochemistry; Estados Unidos
Fil: Kim, Jaeyeon. Baylor College of Medicine. Department of Pathology & Immunology; Estados Unidos. Baylor College of Medicine. Center for Reproductive Medicine; Estados Unidos
Fil: Matzuk, Martin M.. Baylor College of Medicine. Department of Pathology & Immunology; Estados Unidos. Baylor College of Medicine. Department of Molecular and Cellular Biology; Estados Unidos. Baylor College of Medicine. Department of Molecular and Human Genetics; Estados Unidos
Fil: Fernández, Facundo M. . Georgia Institute of Technology. School of Chemistry & Biochemistry; Estados Unidos. Georgia Institute of Technology. Institute of Bioengineering and Biosciences; Estados Unidos - Materia
-
Ovarian Cancer
Mouse Models
Untargeted Metabolomics
Mass Spectrometry
Liquid Chromatography
Biomarkers
Early Detection - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/4099
Ver los metadatos del registro completo
id |
CONICETDig_8306f916f47ac1ca9b73f7dc6825332e |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/4099 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Metabolomic Serum Profiling Detects Early-Stage High-Grade Serous Ovarian Cancer in a Mouse ModelJones, Christina M.Monge, Maria EugeniaKim, JaeyeonMatzuk, Martin M.Fernández, Facundo M. Ovarian CancerMouse ModelsUntargeted MetabolomicsMass SpectrometryLiquid ChromatographyBiomarkersEarly Detectionhttps://purl.org/becyt/ford/1.4https://purl.org/becyt/ford/1https://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Ovarian cancer is a deadly disease killing more than any other gynecologic cancer. Nonspecific symptoms, combined with a lack of early detection methods, contribute to late diagnosis and low five-year survival rates. High-grade serous carcinoma (HGSC) is the most common and deadliest subtype that results in 90% of ovarian cancer deaths. To investigate metabolic patterns for early detection of this deadly ovarian cancer, Dicer- Pten double knockout (DKO) mice that phenocopy many of the features of metastatic HGSC observed in women were studied. Using ultraperformance liquid chromatography−mass spectrometry (UPLC−MS), serum samples from 14 early-stage tumor (ET) DKO mice and 11 controls were analyzed in depth to screen for metabolic signatures capable of differentiating early-stage HGSC from controls. Iterative multivariate classification selected 18 metabolites that, when considered as a panel, yielded 100% accuracy, sensitivity, and specificity for classification. Altered metabolic pathways reflected in that panel included those of fatty acids, bile acids, glycerophospholipids, peptides, and some dietary phytochemicals. These alterations revealed impacts to cellular energy storage and membrane stability, as well as changes in defenses against oxidative stress, shedding new light on the metabolic alterations associated with early ovarian cancer stages.Fil: Jones, Christina M.. Georgia Institute of Technology. School of Chemistry & Biochemistry; Estados UnidosFil: Monge, Maria Eugenia. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Bionanociencias "Elizabeth Jares Erijman"; Argentina. Georgia Institute of Technology. School of Chemistry & Biochemistry; Estados UnidosFil: Kim, Jaeyeon. Baylor College of Medicine. Department of Pathology & Immunology; Estados Unidos. Baylor College of Medicine. Center for Reproductive Medicine; Estados UnidosFil: Matzuk, Martin M.. Baylor College of Medicine. Department of Pathology & Immunology; Estados Unidos. Baylor College of Medicine. Department of Molecular and Cellular Biology; Estados Unidos. Baylor College of Medicine. Department of Molecular and Human Genetics; Estados UnidosFil: Fernández, Facundo M. . Georgia Institute of Technology. School of Chemistry & Biochemistry; Estados Unidos. Georgia Institute of Technology. Institute of Bioengineering and Biosciences; Estados UnidosAmerican Chemical Society2015-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/4099Jones, Christina M.; Monge, Maria Eugenia; Kim, Jaeyeon; Matzuk, Martin M.; Fernández, Facundo M. ; Metabolomic Serum Profiling Detects Early-Stage High-Grade Serous Ovarian Cancer in a Mouse Model; American Chemical Society; Journal of Proteome Research; 14; 2; 1-2015; 917-9271535-3893enginfo:eu-repo/semantics/altIdentifier/url/http://pubs.acs.org/doi/abs/10.1021/pr5009948info:eu-repo/semantics/altIdentifier/doi/DOI:10.1021/pr5009948info:eu-repo/semantics/altIdentifier/issn/1535-3893info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:41:32Zoai:ri.conicet.gov.ar:11336/4099instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:41:33.113CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Metabolomic Serum Profiling Detects Early-Stage High-Grade Serous Ovarian Cancer in a Mouse Model |
title |
Metabolomic Serum Profiling Detects Early-Stage High-Grade Serous Ovarian Cancer in a Mouse Model |
spellingShingle |
Metabolomic Serum Profiling Detects Early-Stage High-Grade Serous Ovarian Cancer in a Mouse Model Jones, Christina M. Ovarian Cancer Mouse Models Untargeted Metabolomics Mass Spectrometry Liquid Chromatography Biomarkers Early Detection |
title_short |
Metabolomic Serum Profiling Detects Early-Stage High-Grade Serous Ovarian Cancer in a Mouse Model |
title_full |
Metabolomic Serum Profiling Detects Early-Stage High-Grade Serous Ovarian Cancer in a Mouse Model |
title_fullStr |
Metabolomic Serum Profiling Detects Early-Stage High-Grade Serous Ovarian Cancer in a Mouse Model |
title_full_unstemmed |
Metabolomic Serum Profiling Detects Early-Stage High-Grade Serous Ovarian Cancer in a Mouse Model |
title_sort |
Metabolomic Serum Profiling Detects Early-Stage High-Grade Serous Ovarian Cancer in a Mouse Model |
dc.creator.none.fl_str_mv |
Jones, Christina M. Monge, Maria Eugenia Kim, Jaeyeon Matzuk, Martin M. Fernández, Facundo M. |
author |
Jones, Christina M. |
author_facet |
Jones, Christina M. Monge, Maria Eugenia Kim, Jaeyeon Matzuk, Martin M. Fernández, Facundo M. |
author_role |
author |
author2 |
Monge, Maria Eugenia Kim, Jaeyeon Matzuk, Martin M. Fernández, Facundo M. |
author2_role |
author author author author |
dc.subject.none.fl_str_mv |
Ovarian Cancer Mouse Models Untargeted Metabolomics Mass Spectrometry Liquid Chromatography Biomarkers Early Detection |
topic |
Ovarian Cancer Mouse Models Untargeted Metabolomics Mass Spectrometry Liquid Chromatography Biomarkers Early Detection |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.4 https://purl.org/becyt/ford/1 https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Ovarian cancer is a deadly disease killing more than any other gynecologic cancer. Nonspecific symptoms, combined with a lack of early detection methods, contribute to late diagnosis and low five-year survival rates. High-grade serous carcinoma (HGSC) is the most common and deadliest subtype that results in 90% of ovarian cancer deaths. To investigate metabolic patterns for early detection of this deadly ovarian cancer, Dicer- Pten double knockout (DKO) mice that phenocopy many of the features of metastatic HGSC observed in women were studied. Using ultraperformance liquid chromatography−mass spectrometry (UPLC−MS), serum samples from 14 early-stage tumor (ET) DKO mice and 11 controls were analyzed in depth to screen for metabolic signatures capable of differentiating early-stage HGSC from controls. Iterative multivariate classification selected 18 metabolites that, when considered as a panel, yielded 100% accuracy, sensitivity, and specificity for classification. Altered metabolic pathways reflected in that panel included those of fatty acids, bile acids, glycerophospholipids, peptides, and some dietary phytochemicals. These alterations revealed impacts to cellular energy storage and membrane stability, as well as changes in defenses against oxidative stress, shedding new light on the metabolic alterations associated with early ovarian cancer stages. Fil: Jones, Christina M.. Georgia Institute of Technology. School of Chemistry & Biochemistry; Estados Unidos Fil: Monge, Maria Eugenia. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Bionanociencias "Elizabeth Jares Erijman"; Argentina. Georgia Institute of Technology. School of Chemistry & Biochemistry; Estados Unidos Fil: Kim, Jaeyeon. Baylor College of Medicine. Department of Pathology & Immunology; Estados Unidos. Baylor College of Medicine. Center for Reproductive Medicine; Estados Unidos Fil: Matzuk, Martin M.. Baylor College of Medicine. Department of Pathology & Immunology; Estados Unidos. Baylor College of Medicine. Department of Molecular and Cellular Biology; Estados Unidos. Baylor College of Medicine. Department of Molecular and Human Genetics; Estados Unidos Fil: Fernández, Facundo M. . Georgia Institute of Technology. School of Chemistry & Biochemistry; Estados Unidos. Georgia Institute of Technology. Institute of Bioengineering and Biosciences; Estados Unidos |
description |
Ovarian cancer is a deadly disease killing more than any other gynecologic cancer. Nonspecific symptoms, combined with a lack of early detection methods, contribute to late diagnosis and low five-year survival rates. High-grade serous carcinoma (HGSC) is the most common and deadliest subtype that results in 90% of ovarian cancer deaths. To investigate metabolic patterns for early detection of this deadly ovarian cancer, Dicer- Pten double knockout (DKO) mice that phenocopy many of the features of metastatic HGSC observed in women were studied. Using ultraperformance liquid chromatography−mass spectrometry (UPLC−MS), serum samples from 14 early-stage tumor (ET) DKO mice and 11 controls were analyzed in depth to screen for metabolic signatures capable of differentiating early-stage HGSC from controls. Iterative multivariate classification selected 18 metabolites that, when considered as a panel, yielded 100% accuracy, sensitivity, and specificity for classification. Altered metabolic pathways reflected in that panel included those of fatty acids, bile acids, glycerophospholipids, peptides, and some dietary phytochemicals. These alterations revealed impacts to cellular energy storage and membrane stability, as well as changes in defenses against oxidative stress, shedding new light on the metabolic alterations associated with early ovarian cancer stages. |
publishDate |
2015 |
dc.date.none.fl_str_mv |
2015-01 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/4099 Jones, Christina M.; Monge, Maria Eugenia; Kim, Jaeyeon; Matzuk, Martin M.; Fernández, Facundo M. ; Metabolomic Serum Profiling Detects Early-Stage High-Grade Serous Ovarian Cancer in a Mouse Model; American Chemical Society; Journal of Proteome Research; 14; 2; 1-2015; 917-927 1535-3893 |
url |
http://hdl.handle.net/11336/4099 |
identifier_str_mv |
Jones, Christina M.; Monge, Maria Eugenia; Kim, Jaeyeon; Matzuk, Martin M.; Fernández, Facundo M. ; Metabolomic Serum Profiling Detects Early-Stage High-Grade Serous Ovarian Cancer in a Mouse Model; American Chemical Society; Journal of Proteome Research; 14; 2; 1-2015; 917-927 1535-3893 |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/http://pubs.acs.org/doi/abs/10.1021/pr5009948 info:eu-repo/semantics/altIdentifier/doi/DOI:10.1021/pr5009948 info:eu-repo/semantics/altIdentifier/issn/1535-3893 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
American Chemical Society |
publisher.none.fl_str_mv |
American Chemical Society |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613311240339456 |
score |
13.070432 |